Notice2026-05853

Certain Hydrodermabrasion Systems and Components Thereof; Notice of the Commission's Final Determination Finding a Violation of Section 337: Issuance and Suspension of Limited Exclusion Order and Cease and Desist Order; Termination of the Investigation

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 26, 2026

Issuing agencies

International Trade Commission

Abstract

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined that that a violation under of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337) has occurred. The Commission has determined that the appropriate remedy is to issue a limited exclusion order and a cease and desist order and set the bond at zero percent (0%) of the entered value of the covered products during the period of Presidential review. However, the Commission has determined to suspend the issuance of the remedial orders in this investigation given the impending expiration of the asserted patent mere days into the period of Presidential review and the bond having been set at zero percent (0%). The investigation is terminated.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 58 (Thursday, March 26, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 58 (Thursday, March 26, 2026)]
[Notices]
[Pages 14713-14714]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-05853]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1408]


Certain Hydrodermabrasion Systems and Components Thereof; Notice 
of the Commission's Final Determination Finding a Violation of Section 
337: Issuance and Suspension of Limited Exclusion Order and Cease and 
Desist Order; Termination of the Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission (``Commission'') has determined that that a violation under 
of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337) 
has occurred. The Commission has determined that the appropriate remedy 
is to issue a limited exclusion order and a cease and desist order and 
set the bond at zero percent (0%) of the entered value of the covered 
products during the period of Presidential review. However, the 
Commission has determined to suspend the issuance of the remedial 
orders in this investigation given the impending expiration of the 
asserted patent mere days into the period of Presidential review and 
the bond having been set at zero percent (0%). The investigation is 
terminated.

FOR FURTHER INFORMATION CONTACT: Jonathan D. Link, Esq., Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-3103. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>. For help accessing EDIS, please email 
<a href="/cdn-cgi/l/email-protection#7237363b21413a171e023207011b06115c151d04"><span class="__cf_email__" data-cfemail="91d4d5d8c2a2d9f4fde1d1e4e2f8e5f2bff6fee7">[email&#160;protected]</span></a>. General information concerning the Commission may 
also be obtained by accessing its internet server at <a href="https://www.usitc.gov">https://www.usitc.gov</a>. Hearing-impaired persons are advised that information on 
this matter can be obtained by contacting the Commission's TDD terminal 
on (202) 205-1810.

SUPPLEMENTARY INFORMATION: On July 17, 2024, the Commission instituted 
this investigation based on a complaint filed on behalf of HydraFacial 
LLC, f/k/a Edge Systems LLC, of Long Beach, California 
(``HydraFacial''). 89 FR 58188-89 (July 17, 2024). The complaint 
alleges violations of section 337 of the Tariff Act of 1930, as 
amended, 19 U.S.C. 1337 (``section 337''), based on the importation 
into the United States, the sale for importation, or sale within the 
United States after importation of certain hydrodermabrasion systems 
and components thereof by reason of the infringement of certain claims 
of the '287 patent. Id. The complaint further alleges that an industry 
in the United States exists as required by section 337. Id. The 
Commission's notice of investigation named as respondents Cartessa 
Aesthetics, LLC (``Cartessa'') of Melville, New York; and Eunsung 
Global Corp. of Republic of Korea. Id. The Office of Unfair Import 
Investigations is not participating in this investigation. Id.
    On August 14, 2025, the Commission determined not to review an 
initial determination (Order No. 3) setting the target date for 
completion of the investigation as December 17, 2025. See Order No. 3 
(July 29, 2024), unreviewed by Comm'n Notice (Aug. 14, 2024).
    On January 21, 2025, the Commission terminated the investigation as 
to Eunsung based on a consent order. Order No. 19 (Dec. 19, 2024), 
unreviewed by Comm'n Notice (Jan. 21, 2025).
    On April 11, 2025, the Commission determined not to review an 
initial determination (Order No. 34) granting Complainant's unopposed 
motion to terminate the investigation as to claims 1-10, 15, 17, 20, 
23, 26, 28-31, 33-37,

[[Page 14714]]

and 39-45 of the '287 patent. See Order No. 34 (Mar. 26, 2025), 
unreviewed by Comm'n Notice (Apr. 11, 2025).
    On August 26, 2025, the ALJ issued a final initial determination 
(``FID'') finding a violation of section 337 by respondent Cartessa. On 
September 8, 2025, Cartessa filed a petition for review of the FID and 
on September 16, 2025, HydraFacial filed its response.
    On December 15, 2025, the Commission determined, in view of the 
shutdown of the Federal Government, to extend the date for determining 
whether to review the FID to January 22, 2026. See Comm'n Notice (Dec. 
15, 2025). In that notice, the Commission also asked the parties to 
address the impact, if any, the upcoming expiration of the '287 patent 
would have on the investigation.
    On January 22, 2026, the Commission determined to review the FID's 
findings on (1) the construction, and findings on infringement and the 
technical prong of the domestic industry, for the claim limitations 
including the term ``fluid communication''; (2) invalidity and non-
infringement findings based on the finding that the term ``block'' is 
indefinite, including review of any underlying related orders (e.g., 
Order Nos. 29 and 50); and (3) unenforceability based on prosecution 
laches. 91 FR 3540 (Jan. 27, 2026). The Commission sought briefing on 
remedy, the public interest, and bonding. Id. The Commission also 
determined to extend the target date for completion of the 
investigation to March 23, 2026. Id.
    On January 28, 2026, Cartessa filed a motion to terminate the 
present investigation and vacate the FID on Violation of Section 337 
(``Motion to Terminate'') based on the impending expiration of the '287 
patent. On February 9, 2026, HydraFacial filed its opposition to the 
Motion to Terminate.
    On February 5, 2026, HydraFacial and Cartessa submitted their 
initial submissions on remedy, bonding and the public interest. On 
February 12, 2026, HydraFacial and Cartessa submitted responses to the 
other's initial submission. The Commission also received public 
interest comments from interested third parties Sinclair Pharma 
Limited, Sinclair Pharma US, Viora, Inc., EMA Aesthetics, Ltd., 
Aesthetic Management Partners, LLC, and Aesthetic Management Partners, 
Inc.
    Having considered the parties' submissions, the FID, and the record 
in this investigation, the Commission, on review, has determined to 
supplement and affirm the FID's finding that Cartessa has violated 
section 337 by importing into the United States and selling in the 
United States after importation certain hydrodermabrasion systems and 
components thereof that infringe claims 11, 12, 14, 16, 18, 19, 22, 24, 
and 25 of the '287 patent. Specifically, the Commission (1) affirms and 
supplement the FID's the construction, and findings on infringement and 
the technical prong of the domestic industry, for the claim limitations 
including the term ``fluid communication;'' (2) vacates the FID's 
finding that the term ``block'' is indefinite and finds that 
Complainant has waived its allegations as to where claim 32 is 
infringed; (3) and supplements and affirms the FID's finding that the 
'287 patent is not unenforceable based on prosecution laches. 
Accordingly, and in conjunction with the Commission's earlier 
determination not to review the FID's validity and economic domestic 
industry findings for the '287 patent, the Commission's final 
determination in this investigation is that Cartessa violated section 
337 with respect to '287 patent.
    The Commission has determined that the appropriate remedy is a 
limited exclusion order against Respondent Cartessa prohibiting entry 
of products that infringe one or more of the asserted claims of the 
'287 patent, and a cease and desist order. The Commission has further 
determined that the public interest factors enumerated in subsections 
(d)(l) (19 U.S.C. 1337(d)(l)) do not preclude issuance of the above 
referenced remedial orders. Additionally, the Commission has determined 
that the appropriate bond in this investigation would be set at zero 
percent (0%) of entered value of the covered products during the period 
of Presidential review. 19 U.S.C. 1337(j). The Commission, however, has 
determined to suspend enforcement of the orders. The '287 patent will 
expire on March 29, 2026, only six days after the remedial orders issue 
and before the conclusion of the Presidential review period when such 
orders would be enforced. Because of the Commission determination that 
bond for this investigation be set at zero percent (0%) during the 
period of Presidential review and the impending expiration of the '287 
patent during the period of Presidential review, the Commission's 
orders will not have any future remedial effect.
    The Commission has further determined that Cartessa's Motion to 
Terminate is denied as untimely. 19 CFR 210.21(a)(1). The investigation 
is terminated.
    The Commission's orders and opinion were delivered to the President 
and United States Trade Representative on the day of their issuance.
    The Commission vote for this determination took place on March 23, 
2026.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: March 23, 2026.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2026-05853 Filed 3-25-26; 8:45 am]
BILLING CODE 7020-02-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on March 26, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.